MA32945B1 - Tétrahydropyrane spiro pyrrolidinone et pipéridinone substituées, leur préparation et leur utilisation thérapeutique - Google Patents
Tétrahydropyrane spiro pyrrolidinone et pipéridinone substituées, leur préparation et leur utilisation thérapeutiqueInfo
- Publication number
- MA32945B1 MA32945B1 MA33989A MA33989A MA32945B1 MA 32945 B1 MA32945 B1 MA 32945B1 MA 33989 A MA33989 A MA 33989A MA 33989 A MA33989 A MA 33989A MA 32945 B1 MA32945 B1 MA 32945B1
- Authority
- MA
- Morocco
- Prior art keywords
- substituted
- preparation
- treatment
- tetrahydroperan
- biperidenone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
LA PRÉSENTE INVENTION ET CONCERNE UNE SÉRIE DE CARBOXAMIDES DE N-PHÉNYL-BIPYRROLIDINE DE FORMULE (I) DANS LAQUELLE: R1, R2, M, N ET P SONT TELS QUE DÉFINIS DANS LA DESCRIPTION. D'UNE MANIÈRE PLUS SPÉCIFIQUE, LES COMPOSÉS SELON L'INVENTION SONT DES MODULATEURS DES RÉCEPTEURS H3 ET SONT DONC UTILES EN TANT QU'AGENT PHARMACEUTIQUES, NOTAMMENT DANS LE TRAITEMENT ET/OU LA PRÉVENTION DE DIVERSES MALADIES MODULÉES PAR LES RÉCEPTEURS H3 COMPRENANT LES MALADIES ASSOCIÉES AU SYSTÈME CENTRAL NERVEUX. EN OUTRE, LA PRÉSENTE INVENTION CONCERNE ÉGALEMENT DES PROCÉDÉS DE PRÉPARATION DE CARBOXAMIDES DE N-PHÉNYL-BIPYRROLIDINE SUBSTITUÉS ET DES INTERMÉDIAIRES UTILISÉS À CET EFFET.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12008708P | 2008-12-05 | 2008-12-05 | |
FR0955909 | 2009-08-28 | ||
PCT/US2009/066666 WO2010065798A1 (fr) | 2008-12-05 | 2009-12-04 | Pyrrolidinone et pipéridinone spiro à substitution de tétrahydropyranne, sa preparation et son utilisation thérapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
MA32945B1 true MA32945B1 (fr) | 2012-01-02 |
Family
ID=41665099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA33989A MA32945B1 (fr) | 2008-12-05 | 2009-12-04 | Tétrahydropyrane spiro pyrrolidinone et pipéridinone substituées, leur préparation et leur utilisation thérapeutique |
Country Status (27)
Country | Link |
---|---|
US (2) | US8217052B2 (fr) |
EP (1) | EP2373659B1 (fr) |
JP (1) | JP5410544B2 (fr) |
KR (1) | KR101682889B1 (fr) |
CN (1) | CN102239170B (fr) |
AR (1) | AR074467A1 (fr) |
AU (1) | AU2009322243B2 (fr) |
CA (1) | CA2745715C (fr) |
CO (1) | CO6390059A2 (fr) |
CR (1) | CR20110289A (fr) |
DO (1) | DOP2011000166A (fr) |
EC (1) | ECSP11011109A (fr) |
ES (1) | ES2507574T3 (fr) |
HN (1) | HN2011001487A (fr) |
IL (1) | IL213292A (fr) |
MA (1) | MA32945B1 (fr) |
MX (1) | MX2011004791A (fr) |
MY (1) | MY150789A (fr) |
NZ (1) | NZ593150A (fr) |
PA (1) | PA8852301A1 (fr) |
PE (1) | PE20110773A1 (fr) |
RU (1) | RU2519778C2 (fr) |
TN (1) | TN2011000223A1 (fr) |
TW (1) | TWI441826B (fr) |
UA (1) | UA104880C2 (fr) |
WO (1) | WO2010065798A1 (fr) |
ZA (1) | ZA201103261B (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR074466A1 (es) | 2008-12-05 | 2011-01-19 | Sanofi Aventis | Piperidina espiro pirrolidinona y piperidinona sustituidas y su uso terapeutico en enfermedades mediadas por la modulacion de los receptores h3. |
EP2569304A1 (fr) | 2010-05-11 | 2013-03-20 | Sanofi | Bipyrrolidines n-hétéroaryl spirolactame substituées, procédé de préparation et usage thérapeutique associés |
EP2569296A1 (fr) * | 2010-05-11 | 2013-03-20 | Sanofi | Bipyrrolidines n-phényl spirolactame substituées, procédé de préparation et usage thérapeutique associés |
WO2011143162A1 (fr) | 2010-05-11 | 2011-11-17 | Sanofi | Carboxamides de n-hétéroaryl-bipyrrolidine substitués, leur préparation et leur utilisation thérapeutique |
WO2011143161A1 (fr) | 2010-05-11 | 2011-11-17 | Sanofi | Dérivés de n-hétérocycloalkyl-bipyrrolidinylphénylamide substitués, préparation et utilisation thérapeutique de ceux-ci |
EP2569303A1 (fr) | 2010-05-11 | 2013-03-20 | Sanofi | Dérivés n-alkyl et n-acyl tétrahydro-isoquinoline substitués, procédé de préparation et application thérapeutiques associés |
WO2011143150A1 (fr) * | 2010-05-11 | 2011-11-17 | Sanofi | Spirolactames et amides de phénylcycloalkylpyrrolidine (pipéridine) substitués, leur préparation et leur utilisation thérapeutique |
WO2011143155A1 (fr) | 2010-05-11 | 2011-11-17 | Sanofi | Dérivés de n-hétéroaryl tétrahydro-isoquinolines substituées, procédé de préparation et usage thérapeutique associés |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3256276A (en) * | 1961-02-17 | 1966-06-14 | Geschickter Fund Med Res | Substituted spiroimides |
US3258276A (en) | 1964-04-06 | 1966-06-28 | Charles E Murcott | Utility chair |
EP2243776A1 (fr) * | 2001-10-12 | 2010-10-27 | High Point Pharmaceuticals, LLC | Piperidines substituées et leur utilisation dans le traitement de maladies liées au recepteur histaminique H3 |
US6889262B1 (en) | 2002-06-26 | 2005-05-03 | Advanced Micro Devices, Inc. | Direct transaction mode for peripheral devices |
JP2006505590A (ja) | 2002-10-23 | 2006-02-16 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ヒスタミンh3受容体調節物質としてのフェニルピペリジンおよびフェニルピロリジン |
US7223788B2 (en) | 2003-02-14 | 2007-05-29 | Sanofi-Aventis Deutschland Gmbh | Substituted N-aryl heterocycles, process for their preparation and their use as medicaments |
CA2551037A1 (fr) * | 2003-09-22 | 2005-03-31 | Banyu Pharmaceutical Co., Ltd. | Nouveau derive de piperidine |
ATE523488T1 (de) * | 2005-07-01 | 2011-09-15 | Lilly Co Eli | Histamin-h3-rezeptor-mittel, deren herstellung und therapeutische verwendung |
JP4371164B2 (ja) * | 2005-11-10 | 2009-11-25 | 萬有製薬株式会社 | アザ置換スピロ誘導体 |
AU2006326067A1 (en) | 2005-12-16 | 2007-06-21 | F. Hoffmann-La Roche Ag | Pyrrolo [2 , 3-b] pyridine derivatives as H3 receptor modulators |
US20080247964A1 (en) * | 2006-05-08 | 2008-10-09 | Yuelian Xu | Substituted azaspiro derivatives |
WO2007135111A1 (fr) * | 2006-05-23 | 2007-11-29 | High Point Pharmaceuticals, Llc | Nouveaux médicaments |
CA2656089A1 (fr) | 2006-06-29 | 2008-01-03 | Janssen Pharmaceutica N.V. | Composes de benzylamine substituee |
WO2009039431A2 (fr) | 2007-09-21 | 2009-03-26 | Neurogen Corporation | Amines spirocycliques aryl-condensées substituées |
MX2010004003A (es) | 2007-10-17 | 2010-04-30 | Sanofi Aventis | N-fenil-pirrolidinilmetlipirrolidin amidas sustituidas y uso terapeutico de las mismas. |
BRPI0818581A2 (pt) | 2007-10-17 | 2015-07-21 | Sanofi Aventis | Carboxamidas n-fenil-bipirrolidina substituídas e uso terapêutico das mesmas |
PL2212282T3 (pl) | 2007-10-17 | 2012-02-29 | Sanofi Sa | Podstawione N-fenylo-bipirolidyno-karboksyamidy i ich terapeutyczne zastosowanie |
AR074466A1 (es) | 2008-12-05 | 2011-01-19 | Sanofi Aventis | Piperidina espiro pirrolidinona y piperidinona sustituidas y su uso terapeutico en enfermedades mediadas por la modulacion de los receptores h3. |
-
2009
- 2009-12-03 AR ARP090104667A patent/AR074467A1/es unknown
- 2009-12-04 UA UAA201108412A patent/UA104880C2/uk unknown
- 2009-12-04 JP JP2011539715A patent/JP5410544B2/ja active Active
- 2009-12-04 NZ NZ593150A patent/NZ593150A/xx not_active IP Right Cessation
- 2009-12-04 RU RU2011127382/04A patent/RU2519778C2/ru not_active IP Right Cessation
- 2009-12-04 CN CN200980148490.7A patent/CN102239170B/zh active Active
- 2009-12-04 MY MYPI20112068 patent/MY150789A/en unknown
- 2009-12-04 ES ES09775421.2T patent/ES2507574T3/es active Active
- 2009-12-04 PA PA20098852301A patent/PA8852301A1/es unknown
- 2009-12-04 PE PE2011001127A patent/PE20110773A1/es not_active Application Discontinuation
- 2009-12-04 KR KR1020117014404A patent/KR101682889B1/ko active IP Right Grant
- 2009-12-04 AU AU2009322243A patent/AU2009322243B2/en not_active Ceased
- 2009-12-04 CA CA2745715A patent/CA2745715C/fr not_active Expired - Fee Related
- 2009-12-04 TW TW098141444A patent/TWI441826B/zh not_active IP Right Cessation
- 2009-12-04 MX MX2011004791A patent/MX2011004791A/es active IP Right Grant
- 2009-12-04 WO PCT/US2009/066666 patent/WO2010065798A1/fr active Application Filing
- 2009-12-04 MA MA33989A patent/MA32945B1/fr unknown
- 2009-12-04 EP EP09775421.2A patent/EP2373659B1/fr active Active
-
2011
- 2011-05-05 ZA ZA2011/03261A patent/ZA201103261B/en unknown
- 2011-05-06 TN TN2011000223A patent/TN2011000223A1/fr unknown
- 2011-05-27 CR CR20110289A patent/CR20110289A/es unknown
- 2011-05-31 IL IL213292A patent/IL213292A/en not_active IP Right Cessation
- 2011-06-01 DO DO2011000166A patent/DOP2011000166A/es unknown
- 2011-06-02 CO CO11068492A patent/CO6390059A2/es active IP Right Grant
- 2011-06-02 US US13/151,925 patent/US8217052B2/en active Active
- 2011-06-03 HN HN2011001487A patent/HN2011001487A/es unknown
- 2011-06-03 EC EC2011011109A patent/ECSP11011109A/es unknown
-
2012
- 2012-05-30 US US13/483,503 patent/US8383814B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
EA201071169A1 (ru) | ГИДРОКСИМЕТИЛПИРРОЛИДИНЫ В КАЧЕСТВЕ АГОНИСТОВ АДРЕНЕРГИЧЕСКИХ РЕЦЕПТОРОВ β3 | |
EA201071045A1 (ru) | Соединения оксадиазоантрацена для лечения диабета | |
MA32943B1 (fr) | Piperidine spiro pyrrolidione et piperidinone substituees, leur preparation et leur utilisation therapeutique | |
EA201001647A1 (ru) | Производные бензофурана, бензотиофена, бензотиазола в качестве fxr модуляторов | |
ECSP10010582A (es) | Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer | |
EA201001639A1 (ru) | Композиции и способы их получения и применения | |
EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
EA201190235A1 (ru) | Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750 | |
MA32945B1 (fr) | Tétrahydropyrane spiro pyrrolidinone et pipéridinone substituées, leur préparation et leur utilisation thérapeutique | |
EA201270575A1 (ru) | Соединения | |
EA201100299A1 (ru) | Органические соединения | |
EA201170772A1 (ru) | Органические соединения | |
DE602006006712D1 (de) | Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren | |
EA200970967A1 (ru) | Оксадиазол замещенные производные индазола для применения в качестве агонистов сфингозин 1-фосфата (sip) | |
MA32811B1 (fr) | Nouveaux composés | |
EA201391720A1 (ru) | Замещенные диоксопиперидинилфталимидные производные | |
EA201500953A1 (ru) | 3-ацетиламино-1-(фенилгетероариламинокарбонил или фенилгетероарилкарбониламино)бензольные производные для лечения гиперпролиферативных нарушений | |
EA201170356A1 (ru) | Полиморфные и аморфные формы лакозамида и аморфные композиции | |
EA201491028A8 (ru) | Способ получения замещенных 5-фтор-1н-пиразолопиридинов | |
MA32723B1 (fr) | Derives d'anilino-pyrimidine a substitution sulfoximine en tant qu'inhibiteurs de cdk, leur preparation et leur utilisation comme medicaments | |
EA200970065A1 (ru) | Производные пиперазинила, предназначенные для лечения заболеваний, опосредованных рецептором gpr38 | |
MA32505B1 (fr) | 5-alcynyl-pyrimidines | |
EA200970583A1 (ru) | Способ получения пиперазиниловых и диазепаниловых производных бензамида | |
EA200900090A1 (ru) | Бензиламины, способ их получения и их применение в качестве противовоспалительных средств |